K. Okuma

发表

The Novel CXCR 4 Antagonist KRH-3955 Is an Orally Bioavailable and Extremely Potent Inhibitor of Human Immunodeficiency Virus Type 1 Infection : Comparative Studies with AMD 3100

Yuetsu Tanaka, N. Yamamoto, Wei Huang, 2009 .

The Novel CXCR4 Antagonist KRH-3955 Is an Orally Bioavailable and Extremely Potent Inhibitor of Human Immunodeficiency Virus Type 1 Infection: Comparative Studies with AMD3100

Yuetsu Tanaka, N. Yamamoto, Wei Huang, 2009, Antimicrobial Agents and Chemotherapy.

Evaluation of in vitro screening and diagnostic kits for hepatitis C virus infection.

M. Muramatsu, S. Matsuoka, T. Wakita, 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Host Range of Human T-Cell Leukemia Virus Type I Analyzed by a Cell Fusion-Dependent Reporter Gene Activation Assay

Y. Matsuura, Minoru Nakamura, Y. Niho, 1999 .

Safety of convalescent plasma therapy for COVID-19 patients and analysis of viral kinetics: a single-center, open-label, single-arm, interventional study in Japan

M. Satake, Y. Takamatsu, S. Kutsuna, 2022, GHM Open.

Development of a Novel Surrogate Virus for Human T-Cell Leukemia Virus Type 1: Inhibition of Infection by Osteoprotegerin

E. Ramsburg, J. Rose, L. Buonocore, 2003, Journal of Virology.

Analysis of the molecules involved in human T-cell leukaemia virus type 1 entry by a vesicular stomatitis virus pseudotype bearing its envelope glycoproteins.

Y. Matsuura, Y. Yanagi, M. Nakamura, 2001, The Journal of general virology.

Activation of PERK-ATF4-CHOP pathway as a novel therapeutic approach for efficient elimination of HTLV-1-infected cells.

S. Matsuoka, K. Uchimaru, S. Oyadomari, 2020, Blood advances.

Estimation of lactose interference in vaccines and a proposal of methodological adjustment of total protein determination by the lowry method.

I. Hamaguchi, H. Kusunoki, K. Okuma, 2012, Japanese journal of infectious diseases.

INVESTIGATIONS OF ADVERSE TRANSFUSION REACTIONS ACCORDING TO CLINICAL DEPARTMENTS OF UNIVERSITY HOSPITALS IN JAPAN

I. Hamaguchi, S. Hino, H. Ishii, 2016 .

Online reporting system for transfusion-related adverse events to enhance recipient haemovigilance in Japan: a pilot study.

K. Yamaguchi, Y. Ohkusa, M. Taneichi, 2013, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Rapid induction of OX40 ligand on primary T cells activated under DNA-damaging conditions.

Yuetsu Tanaka, G. Matsuzaki, K. Kondo, 2008, Human immunology.

Frequent horizontal and mother-to-child transmission may contribute to high prevalence of STLV-1 infection in Japanese macaques

M. Matsuoka, J. Yasunaga, H. Akari, 2020, Retrovirology.

Generation of Mature Dendritic Cells with Unique Phenotype and Function by In Vitro Short-Term Culture of Human Monocytes in the Presence of Interleukin-4 and Interferon-β

Yuetsu Tanaka, K. Kondo, R. Tanaka, 2008, Experimental biology and medicine.

Cross-Linking Cell Surface Chemokine Receptors Leads to Isolation, Activation, and Differentiation of Monocytes into Potent Dendritic Cells

Yuetsu Tanaka, N. Yamamoto, R. Tanaka, 2006, Experimental biology and medicine.

How we secured a COVID‐19 convalescent plasma procurement scheme in Japan

M. Satake, S. Kutsuna, N. Ohmagari, 2021, Transfusion.

Development of an infectious surrogate hepatitis C virus based on a recombinant vesicular stomatitis virus expressing hepatitis C virus envelope glycoproteins and green fluorescent protein.

J. Rose, L. Buonocore, M. Hiyoshi, 2015, Japanese journal of infectious diseases.

Hemophagocytic syndrome associated with fulminant ulcerative colitis and presumed acute pancreatitis

S. Yoshizawa, Minoru Nakamura, Y. Niho, 1998, American Journal of Gastroenterology.

Dermatomyositis associated with invasive thymoma.

T. Ago, Y. Niho, Y. Kaji, 1999, Internal medicine.

HTLV-1 targets human placental trophoblasts in seropositive pregnant women.

T. Tsukiyama, S. Matsuoka, E. Sasaki, 2020, The Journal of clinical investigation.

A recombinant vesicular stomatitis virus encoding HIV-1 receptors and human OX40 ligand efficiently eliminates HIV-1-infected CD4-positive T cells expressing OX40.

K. Yamaguchi, Yuetsu Tanaka, I. Hamaguchi, 2011, Human immunology.

First case of molecularly identified and genetically characterized human T-cell leukemia virus type 2 infection in a pregnant woman in non-endemic Japan.

M. Kuroda, T. Sekizuka, I. Hamaguchi, 2020, Journal of virological methods.

Virus Entry Is a Major Determinant of Cell Tropism of Edmonston and Wild-Type Strains of Measles Virus as Revealed by Vesicular Stomatitis Virus Pseudotypes Bearing Their Envelope Proteins

Y. Matsuura, A. Takade, Y. Yanagi, 2000, Journal of Virology.

Vaccination with short-term-cultured autologous PBMCs efficiently activated STLV-1-specific CTLs in naturally STLV-1-infected Japanese monkeys with impaired CTL responses

T. Masuda, M. Kannagi, J. Fujisawa, 2023, PLoS pathogens.

Cytolytic Recombinant Vesicular Stomatitis Viruses Expressing STLV-1 Receptor Specifically Eliminate STLV-1 Env-Expressing Cells in an HTLV-1 Surrogate Model In Vitro

H. Akari, I. Hamaguchi, K. Okuma, 2022, Viruses.

Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor

Yuetsu Tanaka, S. Matsuoka, I. Hamaguchi, 2017, Journal of Virology.

Identification of a novel bovine serum protein which is involved in human T-cell leukemia virus type I (HTLV-I)-induced syncytium formation

Y. Niho, S. Nakano, K. Okuma, 1999, Archives of Virology.

Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants

M. Ohnishi, Shigeki Nakamura, N. Tachikawa, 2021, Immunity.

A recombinant vesicular stomatitis virus encoding CCR5-tropic HIV-1 receptors targets HIV-1-infected cells and controls HIV-1 infection.

Mamoru Ito, Yuetsu Tanaka, J. Rose, 2017, Microbes and infection.

Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis.

M. Satake, Toshiki Watanabe, I. Hamaguchi, 2016, The Lancet. Infectious diseases.

Furin-dependent CCL17-fused recombinant toxin controls HTLV-1 infection by targeting and eliminating infected CCR4-expressing cells in vitro and in vivo

M. Saito, S. Okada, Naoki Yamamoto, 2015, Retrovirology.

Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.

Yuetsu Tanaka, N. Yamamoto, K. Kondo, 2007, Human immunology.

UNDERREPORTING IN REPORTING SYSTEM FOR ADVERSE TRANSFUSION REACTIONS

K. Yamaguchi, Y. Ohkusa, I. Hamaguchi, 2015 .

Standardization of Quantitative PCR for Human T-Cell Leukemia Virus Type 1 in Japan: a Collaborative Study

S. Saito, M. Satake, K. Yamaguchi, 2015, Journal of Clinical Microbiology.

Identification of TL-Om1, an Adult T-Cell Leukemia (ATL) Cell Line, as Reference Material for Quantitative PCR for Human T-Lymphotropic Virus 1

K. Sugamura, K. Yamaguchi, Sanaz Firouzi, 2014, Journal of Clinical Microbiology.

Japan: A Collaborative Study

D. Sasaki, H. Hasegawa, T. Yamochi, 2015 .

Standardization of Quantitative PCR for Human T-cell Leukemia Virus Type 1 in 1 Japan : A Collaborative Study 2 3 Running title : Standardization of HTLV-1 qPCR 4 5

Ochiai, S. Saito, M. Satake, 2015 .

Identification of TL-Om 1 , an ATL Cell Line , as a Reference Material for Human 1 T-Lymphotropic Virus 1 Quantitative PCR

K. Sugamura, K. Yamaguchi, Sanaz Firouzi, 2014 .

Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan

S. Saito, M. Satake, A. Utsunomiya, 2020, Retrovirology.

Proviral Features of Human T Cell Leukemia Virus Type 1 in Carriers with Indeterminate Western Blot Analysis Results

S. Saito, M. Satake, K. Yamaguchi, 2017, Journal of Clinical Microbiology.

S. Saito, M. Satake, A. Utsunomiya, 2020, Retrovirology.

Interleukin-4-transgenic hu-PBL-SCID mice: a model for the screening of antiviral drugs and immunotherapeutic agents against X4 HIV-1 viruses.

Mamoru Ito, W. Sugiura, Yuetsu Tanaka, 2008, The Journal of infectious diseases.

Recombinant vesicular stomatitis viruses encoding simian immunodeficiency virus receptors target infected cells and control infection.

E. Boritz, J. Rose, L. Alexander, 2006, Virology.

Development of a novel dengue virus serotype‐specific multiplex real‐time reverse transcription–polymerase chain reaction assay for blood screening

M. Satake, M. Saijo, I. Kurane, 2016, Transfusion.

HMGA1a is involved in specific splice site regulation of human immunodeficiency virus type 1.

K. Ohe, I. Hamaguchi, K. Okuma, 2011, Biochemical and biophysical research communications.

No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity

S. Kutsuna, N. Ohmagari, I. Hamaguchi, 2021, Journal of Infection and Chemotherapy.

Furin-dependent CCL17-fused recombinant toxin controls HTLV-1 infection by targeting and eliminating infected CCR4-expressing cells in vitro and in vivo

K. Yamaguchi, M. Saito, S. Okada, 2015, Retrovirology.

Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial

Akiko Kimura, M. Satake, Y. Takamatsu, 2023, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Humanized mice generated by intra-bone marrow injection of CD133-positive hematopoietic stem cells: application to HIV-1 research

J. Fujisawa, Masako Nomaguchi, T. Koma, 2023, Frontiers in Virology.

Thymocyte Development of Humanized Mice Is Promoted by Interactions with Human-Derived Antigen Presenting Cells upon Immunization

T. Kinashi, M. Matsumoto, K. Okazaki, 2023, International journal of molecular sciences.

Mouse Models for HTLV-1 Infection and Adult T Cell Leukemia

S. Nakajima, K. Okuma, 2023, International journal of molecular sciences.

Development of reference material with assigned value for human T‐cell leukemia virus type 1 quantitative PCR in Japan

S. Saito, M. Satake, A. Utsunomiya, 2018, Microbiology and immunology.

Establishment of a reference material for standardization of the anti-complementary activity test in intravenous immunoglobulin products used in Japan: A collaborative study.

I. Hamaguchi, M. Ochiai, K. Nojima, 2017, Biologicals (Print).

In Situ Raman Study of Neurodegenerated Human Neuroblastoma Cells Exposed to Outer-Membrane Vesicles Isolated from Porphyromonas gingivalis

T. Kawai, E. Marin, G. Pezzotti, 2023, International journal of molecular sciences.

Development of a novel dengue virus serotype‐specific multiplex real‐time reverse transcription–polymerase chain reaction assay for blood screening

M. Satake, M. Saijo, I. Kurane, 2016, Transfusion.

Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial

S. Kutsuna, N. Ohmagari, I. Hamaguchi, 2023 .

Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay.

Y. Matsuura, M. Nakamura, Y Matsuura, 1999, Virology.

Instantaneous Inactivation of Herpes Simplex Virus by Silicon Nitride Bioceramics

E. Marin, G. Pezzotti, O. Mazda, 2023, International journal of molecular sciences.